To Evaluate safety and efficacy of hair care product.

Not Applicable

• Conditions: Health Condition 1: L649- Androgenic alopecia, unspecified

• Registration Number: CTRI/2021/05/033440
• Lead Sponsor: Sahyadri Bio Labs Pvt Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Having androgenetic alopecia of class I-2 to I-4 according to Ludwig Scale for females and class II

to III (including III, IIIA and IIIvertex) according to Norwood Hamilton Scale for males.

Exclusion Criteria

Having naturally fair or white hair

Having a dermatosis on the scalp

aving history of any harmonal problem.

Having surgery history on the scalp (micro transplants â?¦)

Refusing the shaving of an area of the scalp of about 1.5 cm², the first day of the study and several times during the study

Having presented a factor inducing a telogen effluvium in the 3 months preceding the start of the study (important stress, high feverâ?¦)

Presenting an acute or chronic general desease or pathology which could have an influence on hair

endocrinopathy (diabetes, thyroidâ?¦), high blood pressure, renal problems, hepatic problems,

known anaemia. Having contact allergy or atopic predisposition.

Having history of medical/surgical events that may significantly affect the study outcome eg h/o

typhoid or jaundice etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in hair loss through assessment of AT ratio (Anagen Vs Telogen Ratio)Timepoint: T0, T14, T26,T28,T42,T54,T56, T70,T82,T84,T102,T118, T120.

Secondary Outcome Measures

Name	Time	Method
Assessment of AT ratioTimepoint: T0, T14, T26,T28,T42,T54,T56, T70,T82,T84,T102,T118, T120.